» Articles » PMID: 11786903

Enhanced Pathological Angiogenesis in Mice Lacking Beta3 Integrin or Beta3 and Beta5 Integrins

Overview
Journal Nat Med
Date 2002 Jan 12
PMID 11786903
Citations 245
Authors
Affiliations
Soon will be listed here.
Abstract

Inhibition of alphavbeta3 or alphavbeta5 integrin function has been reported to suppress neovascularization and tumor growth, suggesting that these integrins are critical modulators of angiogenesis. Here we report that mice lacking beta3 integrins or both beta3 and beta5 integrins not only support tumorigenesis, but have enhanced tumor growth as well. Moreover, the tumors in these integrin-deficient mice display enhanced angiogenesis, strongly suggesting that neither beta3 nor beta5 integrins are essential for neovascularization. We also observed that angiogenic responses to hypoxia and vascular endothelial growth factor (VEGF) are augmented significantly in the absence of beta3 integrins. We found no evidence that the expression or functions of other integrins were altered as a consequence of the beta3 deficiency, but we did observe elevated levels of VEGF receptor-2 (also called Flk-1) in beta3-null endothelial cells. These data indicate that alphavbeta3 and alphavbeta5 integrins are not essential for vascular development or pathological angiogenesis and highlight the need for further evaluation of the mechanisms of action of alphav-integrin antagonists in anti-angiogenic therapeutics.

Citing Articles

The interplay of cancer-associated fibroblasts and apoptotic cancer cells suppresses lung cancer cell growth through WISP-1-integrin ανβ3-STAT1 signaling pathway.

Kim S, Yang K, Kim K, Kim H, Kim D, Chae J Cell Commun Signal. 2025; 23(1):98.

PMID: 39966869 PMC: 11837402. DOI: 10.1186/s12964-025-02094-2.


Integrins as Key Mediators of Metastasis.

Caceres-Calle D, Torre-Cea I, Marcos-Zazo L, Carrera-Aguado I, Guerra-Paes E, Berlana-Galan P Int J Mol Sci. 2025; 26(3).

PMID: 39940673 PMC: 11816423. DOI: 10.3390/ijms26030904.


The heparin-binding domain of VEGF165 directly binds to integrin αvβ3 and VEGFR2/KDR D1: a potential mechanism of negative regulation of VEGF165 signaling by αvβ3.

Takada Y, Yu J, Ye X, Wu C, Felding B, Fujita M Front Cell Dev Biol. 2024; 12:1347616.

PMID: 38803393 PMC: 11128890. DOI: 10.3389/fcell.2024.1347616.


The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy.

Carrera-Aguado I, Marcos-Zazo L, Carrancio-Salan P, Guerra-Paes E, Sanchez-Juanes F, Munoz-Felix J Int J Mol Sci. 2024; 25(2).

PMID: 38255995 PMC: 10815934. DOI: 10.3390/ijms25020921.


Genetic deletion or tyrosine phosphatase inhibition of PTPRZ1 activates c-Met to up-regulate angiogenesis and lung adenocarcinoma growth.

Kastana P, Ntenekou D, Mourkogianni E, Enake M, Xanthopoulos A, Choleva E Int J Cancer. 2023; 153(5):1051-1066.

PMID: 37260355 PMC: 10524925. DOI: 10.1002/ijc.34564.